Today: 30 April 2026
Browse Category

NASDAQ:IXHL 4 December 2025 - 15 December 2025

Incannex Healthcare (NASDAQ: IXHL) Stock: FDA Fast Track Catalyst, Nasdaq Compliance Clock, and the Latest Forecasts as of Dec. 15, 2025

Incannex Healthcare (NASDAQ: IXHL) Stock: FDA Fast Track Catalyst, Nasdaq Compliance Clock, and the Latest Forecasts as of Dec. 15, 2025

Incannex Healthcare shares traded near $0.42 early December 15, 2025, after the FDA granted Fast Track designation to its lead sleep apnea drug IHL-42X on December 3. The company also received a Nasdaq bid-price compliance extension to April 2026 and saw updated research coverage from Stonegate Capital Partners in November. Analyst coverage remains limited.
15 December 2025
·

Stock Market Today

  • Hexcel Declares Quarterly Dividend Amid Modest Stock Gains
    April 30, 2026, 11:09 AM EDT. Hexcel Corp (HXL) will trade ex-dividend on August 2, 2024, for its quarterly payout of $0.15 per share, equating to roughly 0.23% of its recent $65.49 stock price. The dividend is payable on August 9. Hexcel's annualized dividend yield stands at approximately 0.92%, based on recent payments. Shares have traded between $58.81 and $77.09 over the past year, with a last trade at $66.20, slightly above the 52-week low. On Wednesday, shares edged up by 0.4%. Dividend Channel notes that while dividends can be unpredictable, historical payment consistency may support investor confidence in Hexcel's payout sustainability.

Latest article

Mastercard Earnings Beat Wall Street, But April Cross-Border Slowdown Hits Stock

Mastercard Earnings Beat Wall Street, But April Cross-Border Slowdown Hits Stock

30 April 2026
Mastercard shares fell 2.7% Thursday despite first-quarter profit and revenue beating estimates, as investors reacted to slower April cross-border spending growth. Adjusted earnings reached $4.60 per share on $8.4 billion revenue. Cross-border volume growth dropped to 9% in April from 13% in Q1, with travel-linked growth at just 2%. Operating expenses rose 13%, including a $202 million restructuring charge.
Why Viavi Solutions Stock Is Surging After a Big Earnings Beat

Why Viavi Solutions Stock Is Surging After a Big Earnings Beat

30 April 2026
Viavi Solutions shares surged about 20% in early U.S. trading after fiscal third-quarter revenue rose 42.8% to $406.8 million, beating estimates. Adjusted earnings reached 27 cents per share, above forecasts. The company projected fourth-quarter revenue of $427 million to $437 million. GAAP profit declined from a year earlier and cash flow was negative for the quarter.
Go toTop